The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Angiotensin Converting Enzyme (ACE) Inhibitors Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Angiotensin Converting Enzyme (ACE) Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Angiotensin Converting Enzyme (ACE) Inhibitors market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hypertension accounting for % of the Angiotensin Converting Enzyme (ACE) Inhibitors global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Sulfhydryl-containing Agents segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Angiotensin Converting Enzyme (ACE) Inhibitors include Abbott Laboratories, Pfizer, Novartis, Merck, and Astra Zeneca, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Angiotensin Converting Enzyme (ACE) Inhibitors market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Sulfhydryl-containing Agents
Dicarboxylate-containing Agents
Phosphonate-containing Agents
Market segment by Application can be divided into
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other
The key market players for global Angiotensin Converting Enzyme (ACE) Inhibitors market are listed below:
Abbott Laboratories
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Angiotensin Converting Enzyme (ACE) Inhibitors product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Angiotensin Converting Enzyme (ACE) Inhibitors, with price, sales, revenue and global market share of Angiotensin Converting Enzyme (ACE) Inhibitors from 2019 to 2022.
Chapter 3, the Angiotensin Converting Enzyme (ACE) Inhibitors competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Angiotensin Converting Enzyme (ACE) Inhibitors breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Angiotensin Converting Enzyme (ACE) Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Angiotensin Converting Enzyme (ACE) Inhibitors.
Chapter 13, 14, and 15, to describe Angiotensin Converting Enzyme (ACE) Inhibitors sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Angiotensin Converting Enzyme (ACE) Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Angiotensin Converting Enzyme (ACE) Inhibitors market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hypertension accounting for % of the Angiotensin Converting Enzyme (ACE) Inhibitors global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Sulfhydryl-containing Agents segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Angiotensin Converting Enzyme (ACE) Inhibitors include Abbott Laboratories, Pfizer, Novartis, Merck, and Astra Zeneca, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Angiotensin Converting Enzyme (ACE) Inhibitors market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Sulfhydryl-containing Agents
Dicarboxylate-containing Agents
Phosphonate-containing Agents
Market segment by Application can be divided into
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other
The key market players for global Angiotensin Converting Enzyme (ACE) Inhibitors market are listed below:
Abbott Laboratories
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Angiotensin Converting Enzyme (ACE) Inhibitors product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Angiotensin Converting Enzyme (ACE) Inhibitors, with price, sales, revenue and global market share of Angiotensin Converting Enzyme (ACE) Inhibitors from 2019 to 2022.
Chapter 3, the Angiotensin Converting Enzyme (ACE) Inhibitors competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Angiotensin Converting Enzyme (ACE) Inhibitors breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Angiotensin Converting Enzyme (ACE) Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Angiotensin Converting Enzyme (ACE) Inhibitors.
Chapter 13, 14, and 15, to describe Angiotensin Converting Enzyme (ACE) Inhibitors sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Angiotensin Converting Enzyme (ACE) Inhibitors Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Sulfhydryl-containing Agents
1.2.3 Dicarboxylate-containing Agents
1.2.4 Phosphonate-containing Agents
1.3 Market Analysis by Application
1.3.1 Overview: Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hypertension
1.3.3 Cardiovascular Diseases
1.3.4 Kidney Diseases
1.3.5 Other
1.4 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size & Forecast
1.4.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume (2017-2028)
1.4.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Price (2017-2028)
1.5 Global Angiotensin Converting Enzyme (ACE) Inhibitors Production Capacity Analysis
1.5.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Total Production Capacity (2017-2028)
1.5.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Angiotensin Converting Enzyme (ACE) Inhibitors Market Drivers
1.6.2 Angiotensin Converting Enzyme (ACE) Inhibitors Market Restraints
1.6.3 Angiotensin Converting Enzyme (ACE) Inhibitors Trends Analysis
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
2.1.4 Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
2.2.4 Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
2.3.4 Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
2.4.4 Merck Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Astra Zeneca
2.5.1 Astra Zeneca Details
2.5.2 Astra Zeneca Major Business
2.5.3 Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
2.5.4 Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Jhonson and Johnson
2.6.1 Jhonson and Johnson Details
2.6.2 Jhonson and Johnson Major Business
2.6.3 Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
2.6.4 Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Eli Lilly
2.7.1 Eli Lilly Details
2.7.2 Eli Lilly Major Business
2.7.3 Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
2.7.4 Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
2.8.4 Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Bristol-Myers Squibb
2.9.1 Bristol-Myers Squibb Details
2.9.2 Bristol-Myers Squibb Major Business
2.9.3 Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
2.9.4 Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Bayer
2.10.1 Bayer Details
2.10.2 Bayer Major Business
2.10.3 Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
2.10.4 Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 GSK
2.11.1 GSK Details
2.11.2 GSK Major Business
2.11.3 GSK Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
2.11.4 GSK Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Teva Pharmaceutical
2.12.1 Teva Pharmaceutical Details
2.12.2 Teva Pharmaceutical Major Business
2.12.3 Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
2.12.4 Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Angiotensin Converting Enzyme (ACE) Inhibitors Breakdown Data by Manufacturer
3.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Angiotensin Converting Enzyme (ACE) Inhibitors
3.4 Market Concentration Rate
3.4.1 Top 3 Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturer Market Share in 2021
3.4.2 Top 6 Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturer Market Share in 2021
3.5 Global Angiotensin Converting Enzyme (ACE) Inhibitors Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Angiotensin Converting Enzyme (ACE) Inhibitors Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Region
4.1.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Region (2017-2028)
4.1.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Region (2017-2028)
4.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (2017-2028)
4.3 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (2017-2028)
4.4 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (2017-2028)
4.5 South America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (2017-2028)
4.6 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Type (2017-2028)
5.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Type (2017-2028)
5.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Application (2017-2028)
6.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Application (2017-2028)
6.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2017-2028)
7.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2017-2028)
7.3 North America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country
7.3.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Country (2017-2028)
7.3.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2017-2028)
8.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2017-2028)
8.3 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country
8.3.1 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Country (2017-2028)
8.3.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2017-2028)
9.2 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2017-2028)
9.3 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Region
9.3.1 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2017-2028)
10.2 South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2017-2028)
10.3 South America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country
10.3.1 South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Country (2017-2028)
10.3.2 South America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2017-2028)
11.2 Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2017-2028)
11.3 Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country
11.3.1 Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Angiotensin Converting Enzyme (ACE) Inhibitors and Key Manufacturers
12.2 Manufacturing Costs Percentage of Angiotensin Converting Enzyme (ACE) Inhibitors
12.3 Angiotensin Converting Enzyme (ACE) Inhibitors Production Process
12.4 Angiotensin Converting Enzyme (ACE) Inhibitors Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Angiotensin Converting Enzyme (ACE) Inhibitors Typical Distributors
13.3 Angiotensin Converting Enzyme (ACE) Inhibitors Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Laboratories Major Business
Table 5. Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
Table 6. Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
Table 10. Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Novartis Basic Information, Manufacturing Base and Competitors
Table 12. Novartis Major Business
Table 13. Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
Table 14. Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
Table 18. Merck Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table 20. Astra Zeneca Major Business
Table 21. Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
Table 22. Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Jhonson and Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Jhonson and Johnson Major Business
Table 25. Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
Table 26. Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 28. Eli Lilly Major Business
Table 29. Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
Table 30. Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Sanofi Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi Major Business
Table 33. Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
Table 34. Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 36. Bristol-Myers Squibb Major Business
Table 37. Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
Table 38. Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Bayer Basic Information, Manufacturing Base and Competitors
Table 40. Bayer Major Business
Table 41. Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
Table 42. Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. GSK Basic Information, Manufacturing Base and Competitors
Table 44. GSK Major Business
Table 45. GSK Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
Table 46. GSK Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 48. Teva Pharmaceutical Major Business
Table 49. Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
Table 50. Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K MT)
Table 52. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Angiotensin Converting Enzyme (ACE) Inhibitors, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Angiotensin Converting Enzyme (ACE) Inhibitors Production Capacity by Company, (K MT): 2020 VS 2021
Table 55. Head Office and Angiotensin Converting Enzyme (ACE) Inhibitors Production Site of Key Manufacturer
Table 56. Angiotensin Converting Enzyme (ACE) Inhibitors New Entrant and Capacity Expansion Plans
Table 57. Angiotensin Converting Enzyme (ACE) Inhibitors Mergers & Acquisitions in the Past Five Years
Table 58. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region (2017-2022) & (K MT)
Table 59. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region (2023-2028) & (K MT)
Table 60. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2017-2022) & (K MT)
Table 63. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2023-2028) & (K MT)
Table 64. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Type (2017-2022) & (USD/Unit)
Table 67. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Type (2023-2028) & (USD/Unit)
Table 68. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2017-2022) & (K MT)
Table 69. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2023-2028) & (K MT)
Table 70. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Application (2017-2022) & (USD/Unit)
Table 73. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Application (2023-2028) & (USD/Unit)
Table 74. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2017-2022) & (K MT)
Table 75. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2023-2028) & (K MT)
Table 76. North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2017-2022) & (K MT)
Table 79. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2023-2028) & (K MT)
Table 80. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2017-2022) & (K MT)
Table 81. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2023-2028) & (K MT)
Table 82. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2017-2022) & (K MT)
Table 83. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2023-2028) & (K MT)
Table 84. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2017-2022) & (K MT)
Table 87. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2023-2028) & (K MT)
Table 88. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2017-2022) & (K MT)
Table 89. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2023-2028) & (K MT)
Table 90. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region (2017-2022) & (K MT)
Table 91. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region (2023-2028) & (K MT)
Table 92. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2017-2022) & (K MT)
Table 95. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2023-2028) & (K MT)
Table 96. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2017-2022) & (K MT)
Table 97. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2023-2028) & (K MT)
Table 98. South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2017-2022) & (K MT)
Table 99. South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2023-2028) & (K MT)
Table 100. South America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2017-2022) & (K MT)
Table 103. South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2023-2028) & (K MT)
Table 104. South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2017-2022) & (K MT)
Table 105. South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2023-2028) & (K MT)
Table 106. Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region (2017-2022) & (K MT)
Table 107. Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region (2023-2028) & (K MT)
Table 108. Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2017-2022) & (K MT)
Table 111. Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2023-2028) & (K MT)
Table 112. Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2017-2022) & (K MT)
Table 113. Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2023-2028) & (K MT)
Table 114. Angiotensin Converting Enzyme (ACE) Inhibitors Raw Material
Table 115. Key Manufacturers of Angiotensin Converting Enzyme (ACE) Inhibitors Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Angiotensin Converting Enzyme (ACE) Inhibitors Typical Distributors
Table 119. Angiotensin Converting Enzyme (ACE) Inhibitors Typical Customers
List of Figures
Figure 1. Angiotensin Converting Enzyme (ACE) Inhibitors Picture
Figure 2. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Type in 2021
Figure 3. Sulfhydryl-containing Agents
Figure 4. Dicarboxylate-containing Agents
Figure 5. Phosphonate-containing Agents
Figure 6. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Application in 2021
Figure 7. Hypertension
Figure 8. Cardiovascular Diseases
Figure 9. Kidney Diseases
Figure 10. Other
Figure 11. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (USD Million) & (K MT): 2017 & 2021 & 2028
Figure 12. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (2017-2028) & (K MT)
Figure 14. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price (2017-2028) & (USD/Unit)
Figure 15. Global Angiotensin Converting Enzyme (ACE) Inhibitors Production Capacity (2017-2028) & (K MT)
Figure 16. Global Angiotensin Converting Enzyme (ACE) Inhibitors Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Angiotensin Converting Enzyme (ACE) Inhibitors Market Drivers
Figure 18. Angiotensin Converting Enzyme (ACE) Inhibitors Market Restraints
Figure 19. Angiotensin Converting Enzyme (ACE) Inhibitors Market Trends
Figure 20. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Manufacturer in 2021
Figure 21. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Manufacturer in 2021
Figure 22. Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Region (2017-2028)
Figure 26. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Region (2017-2028)
Figure 27. North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (2017-2028) & (USD Million)
Figure 28. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (2017-2028) & (USD Million)
Figure 30. South America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (2017-2028) & (USD Million)
Figure 32. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Type (2017-2028)
Figure 33. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Type (2017-2028)
Figure 34. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Type (2017-2028) & (USD/Unit)
Figure 35. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Application (2017-2028)
Figure 36. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Application (2017-2028)
Figure 37. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Application (2017-2028) & (USD/Unit)
Figure 38. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Type (2017-2028)
Figure 39. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Application (2017-2028)
Figure 40. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Country (2017-2028)
Figure 41. North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Country (2017-2028)
Figure 42. United States Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Type (2017-2028)
Figure 46. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Application (2017-2028)
Figure 47. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Country (2017-2028)
Figure 48. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Country (2017-2028)
Figure 49. Germany Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Region (2017-2028)
Figure 58. China Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Type (2017-2028)
Figure 65. South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Application (2017-2028)
Figure 66. South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Country (2017-2028)
Figure 67. South America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Angiotensin Converting Enzyme (ACE) Inhibitors in 2021
Figure 79. Manufacturing Process Analysis of Angiotensin Converting Enzyme (ACE) Inhibitors
Figure 80. Angiotensin Converting Enzyme (ACE) Inhibitors Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
